Loading organizations...
Key people at Nolan Capital.
Nolan Capital functions as a family office and holding company, specializing in long-term equity investments. The firm targets control stakes in U.S. industry leaders with proven management, attractive growth, and competitive advantages. Its investment mandate spans diverse sectors like consumer, industrial, and business services, plus real estate, managed for the Nolan family.
Peter Nolan founded Nolan Capital, Inc. in 2014, establishing it as the holding company for his family’s investments. His core insight was to create a platform for strategic, long-duration investments across varied assets. Nolan’s experience and Cornell University academic background inform the firm’s disciplined investment philosophy.
Serving the Nolan family's investment objectives, the firm's portfolio companies benefit from its capital and strategic guidance. Nolan Capital’s vision centers on fostering sustainable value by partnering with robust businesses for their continued development. This commitment to enduring growth defines its approach.
Key people at Nolan Capital.
Nolan Capital has 2 tracked investments across 2 companies. The latest tracked deal is $37.7M Series D in Palvella Therapeutics in January 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 9, 2023 | Palvella Therapeutics | $37.7M Series D | Gore Range Capital, Tadd S. Wessel | Agent Capital, BioAdvance, BVF Partners, Samsara BioCapital |
| Jul 1, 2020 | Encoded Therapeutics | $140.0M Series D | GV | Menlo Ventures, Anne Wojcicki, ARCH Venture Partners, Boxer Capital, Farallon Capital Management, HBM Genomics, Illumina Ventures, Matrix Capital Management, Anthology Fund, Meritech Capital Partners, Perceptive Advisors, RTW Investments, Softbank |